Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:RXRX   10:02:05 AM EDT
17.61
-0.11 (-0.62%)
Earnings Announcements

Recursion Pharma Reports Qtrly Net Loss Per Share Of $0.28

Published: 11/10/2021 14:33 GMT
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A (RXRX) - Recursion Pharmaceuticals Inc - Qtrly Net Loss per Share of Class A and B Common Stock, Basic and Diluted $0.28.
Recursion Pharmaceuticals Inc - Qtrly Total Revenue $2.5 Million Versus $1 Million.
Revenue is expected to be $5.2 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $2.5 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.